Catch-and-Release Plan for MRI Contrast Agents

  • Author: Jeniffer Calderón Giraldo
  • Published Date: 06 July 2020
  • Source / Publisher: ChemMedChem/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Catch-and-Release Plan for MRI Contrast Agents

Related Societies

Yeast-derived β-glucan particles (GPs) are good delivery vehicles for various kinds of drugs and have an affinity for immune cells. GPs could be used to create contrast agent carriers for magnetic resonance imaging (MRI) that can specifically target macrophages—a type of white blood cell and part of the immune system. The ability to deliver drugs and contrast agents to immune cells simultaneously could be an important theranostic application of GPs. However, encapsulating low-molecular-weight drugs and hydrophilic imaging agents is difficult due to the porous nature of GPs.

Janet R. Morrow, University at Buffalo, State University of New York, Amherst, USA, and colleagues have investigated the use of GPs as delivery vehicles for three macrocyclic high-spin iron(III) complex MRI contrast agents, Fe(TOB), Fe(TOD) and Fe(TOT) (pictured below). The cationic nature of these complexes enables their encapsulation into GPs (which are negatively charged) without additional functionalization. Such cationic contrast agents are unusual: commonly used GdIII‐based MRI contrast agents are typically anionic or neutral. The glucan particles were obtained from yeast cell walls and loaded with the contrast agents in a buffer solution.



The interaction between the contrast agents and the GPs may involve coordination bonds or electrostatic interactions with the β-glucan particles. It is reversible under mild acidic conditions or in the presence of a bidentate maltol chelator, releasing the iron(III) complex from the GPs. According to the researchers, the facile encapsulation of iron(III)-based MRI contrast agents into GPs is promising for the development of theranostic approaches for immune system cells.



Article Views: 1873

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

If you would like to reuse any content, in print or online, from, please contact us first for permission and consult our permission guidance prior to making your request

Follow on Facebook Follow on Twitter Follow on YouTube Follow on LinkedIn Follow on Instagram RSS Sign up for newsletters

Magazine of Chemistry Europe (16 European Chemical Societies) published by Wiley-VCH